Altered levels of mRNA of apoptosis-mediating genes after mid-term mechanical ventricular support in dilative cardiomyopathy--first results of the Halle Assist Induced Recovery Study (HAIR).

No abstract is available for this paper.

• Publication year

  1999

• Venue

  The thoracic and cardiovascular surgeon

• Publication date

  1999-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2007-1013108PMID 10218621
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution of myocyte apoptosis to myocardial infarction?

  1998cited by this paper
• Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell.

  1998cited by this paper
• Alternative splicing of the primary Fas transcript generating soluble Fas antagonists is suppressed in the failing human ventricular myocardium.

  1997cited by this paper
• Mechanical support in dilated cardiomyopathy: signs of early left ventricular recovery.

  1997cited by this paper
• Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy.

  1997cited by this paper
• Improved left ventricular function after chronic left ventricular unloading.

  1996cited by this paper
• [Inflammatory mediators in patients with biventricular assist device systems].

  1996cited by this paper
• Can we treat dilated cardiomyopathy using a left ventricular assist device?

  1996cited by this paper
• Myocyte death in heart failure.

  1996cited by this paper
• Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading.

  1995cited by this paper
• Effect of the implantable left ventricular assist device on neuroendocrine activation in heart failure.

  1995cited by this paper
• Stretch-induced programmed myocyte cell death.

  1995cited by this paper
• Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload.

  1994cited by this paper
• Univentricular and biventricular Thoratec VAD support as a bridge to transplantation.

  1993cited by this paper
• Mildly dilated congestive cardiomyopathy. Use of prospective diagnostic criteria and description of the clinical course without heart transplantation.

  1990cited by this paper
• Thoratec VAD system as a bridge to heart transplantation.

  1990cited by this paper
• Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

  1979cited by this paper

• Detecting Anastasis In Vivo by CaspaseTracker Biosensor.

  2018cites this paper
• Technology & Medicine Open Access book

  2017cites this paper
• Stress Induced Mutagenesis, Genetic Diversification, and Cell Survival via Anastasis, the Reversal of Late Stage Apoptosis

  2013cites this paper
• Molecular changes after left ventricular assist device support for heart failure.

  2013cites this paper
• Bridge to recovery: what remains to be discovered?

  2011cites this paper
• Myocardial Recovery Following Left Ventricular Assist Device Therapy

  2011cites this paper
• The effects of left ventricular assist devices on myocardial function and cardiac nervous system

  2010cites this paper
• Left ventricular remodeling and myocardial recovery on mechanical circulatory support.

  2010cites this paper
• Physiologic benefits of pulsatile perfusion during mechanical circulatory support for the treatment of acute and chronic heart failure in adults.

  2010cites this paper
• Prolonged mechanical unloading preserves myocardial contractility but impairs relaxation in rat heart of dilated cardiomyopathy accompanied by myocardial stiffness and apoptosis.

  2010cites this paper
• Molecular Changes Occurring During Reverse Remodelling Following Left Ventricular Assist Device Support

  2010cites this paper
• Mechanical unloading and β2-adrenoceptor stimulation for the treatment of heart failure.

  2009cites this paper
• Qualitative und quantitative Untersuchungen zur Apoptose in der humanen Herzinsuffizienz

  2009cites this paper
• Left ventricular assist device-induced molecular changes in the failing myocardium

  2008cites this paper
• Myocyte deficiency as a target in the treatment of cardiomyopathy

  2007cites this paper
• Mechanisms of Disease: apoptosis in heart failure—seeing hope in death

  2006cites this paper
• Entwöhnung von „assist device“: Mechanische Entlastung und funktionelle Erholung des Herzens

  2006cites this paper
• Is the myofibrillarlytic myocyte a forme fruste apoptotic myocyte?

  2005cites this paper
• Ventricular assist devices: Destination therapy or just another stop on the road?

  2004cites this paper
• Ventricular assist devices as destination therapy.

  2004cites this paper
• Proteomics strategies in cardiovascular research.

  2004cites this paper
• Destination therapy in late-stage heart failure

  2004cites this paper
• Molecular biology of myocardial recovery.

  2004cites this paper
• Bridge to recovery with the use of left ventricular assist device and clenbuterol.

  2003cites this paper
• Non-invasive assessment of myocardial recovery on chronic left ventricular assist device: results associated with successful device removal.

  2003cites this paper
• What Price Support? Ventricular Assist Device Induced Systemic Response

  2003cites this paper
• and failing hearts Heterotopic transplantation as a model to study functional recovery of unloaded

  2002cites this paper
• Heterotopic transplantation as a model to study functional recovery of unloaded failing hearts.

  2002cites this paper
• Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling.

  2002cites this paper
• Emergence of Laplace therapeutics: declaring an end to end-stage heart failure.

  2002cites this paper
• Apoptosis in the ischemic reperfused myocardium

  2001cites this paper
• Apoptosis and the systolic dysfunction in congestive heart failure. Story of apoptosis interruptus and zombie myocytes.

  2001cites this paper
• The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types.

  2001cites this paper
• Left ventricular assist device bridge to recovery: a review of the current status.

  2001cites this paper
• Healing the heart with ventricular assist device therapy: mechanisms of cardiac recovery.

  2001cites this paper
• Left Ventricular Assist Device as a Bridge to Recovery: Present Status

  2001cites this paper
• Update on left ventricular assist devices as a bridge to recovery

  2001cites this paper
• Unresolved issues regarding the role of apoptosis in the pathogenesis of ischemic injury and heart failure.

  2000cites this paper
• The implications for cardiac recovery of left ventricular assist device support on myocardial collagen content.

  2000cites this paper
• Metabolic aspects of programmed cell survival and cell death in the heart.

  2000cites this paper